Diabetes

SEC16B Gene Controls Blood Sugar Through Insulin-Producing Cells

New research reveals how SEC16B protein regulates glucose homeostasis by controlling insulin secretion in pancreatic beta cells.

New GLP-1 Drug Design Shows Superior Weight Loss in Mice

Novel GLP-1 analogue NNC5840 achieves greater weight reduction than semaglutide by optimizing receptor signaling bias rather than potency.

New TyG-ABSI Index Outperforms Traditional Markers for Heart Disease Risk

Large NHANES study shows TyG-ABSI index better predicts cardiovascular disease and death in metabolic syndrome patients than standard measures.

Asia-Pacific Diabetes Advocacy Reveals Massive Healthcare Gaps Across 589M Patients

New review exposes stark disparities in diabetes care across Asia-Pacific, from insulin access to advanced technologies like CGM and pumps.

FDA Approves Two New Weight Loss Drugs in Record Two-Week Span

Foundayo and Zepbound receive rapid FDA approval for chronic weight management in adults with obesity or weight-related conditions.

Drug Approval

Hexokinase Method Emerges as Gold Standard for Accurate Glucose Measurement

Comprehensive review reveals hexokinase method as the most precise technique for glucose testing in clinical laboratories.

Kenya's Diabetes Care System Reveals Complex Barriers to Effective Treatment

Systems analysis of Kenya's diabetes care exposes interconnected failures across governance, workforce, and financing that block quality treatment.

Protein Biomarkers Dramatically Improve Type 2 Diabetes Risk Prediction

Large-scale protein analysis enhanced diabetes risk prediction by 23-29%, offering new tools for early prevention strategies.

Continuous Glucose Monitors Beat Finger Pricks for Pregnant Women with Diabetes

New study shows CGMs improve blood sugar control and birth outcomes compared to traditional glucose testing during pregnancy.

Topical Steroid Withdrawal Linked to Mitochondrial NAD+ Excess, Treatable with Metformin

NIH study identifies metabolic mechanism behind controversial skin condition and demonstrates successful treatment with mitochondrial complex I inhibitors.

MASLD Follows Daily Rhythm Driven by Nighttime Insulin Resistance

New research reveals fatty liver disease follows circadian patterns linked to insulin resistance and reduced nighttime insulin availability.